Sperling, Adam S.
Gibson, Christopher J.
Ebert, Benjamin L.
Article History
First Online: 11 November 2016
Competing interests
: B.L.E. receives research funding from Celgene, consulting fees from H3 Biomedicine, and consulting fees and patent royalties from Genoptix. The other authors declare no competing interests.